Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Larsen, Thomas Stauffer"" wg kryterium: Autor


Tytuł :
Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results
Autorzy :
Christlieb, Sofie Bæk
Strandholdt, Casper Nørgaard
Olsen, Birgitte Brinkmann
Mylam, Karen Juul
Larsen, Thomas Stauffer
Nielsen, Anne Lerberg
Rohde, Max
Gerke, Oke
Olsen, Karen Ege
Møller, Michael Boe
Kristensen, Bjarne Winther
Abildgaard, Niels
Alavi, Abass
Høilund-Carlsen, Poul Flemming
Pokaż więcej
Źródło :
European Journal of Nuclear Medicine and Molecular Imaging. September 2016 43(10):1824-1836
Czasopismo naukowe
Tytuł :
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations
Autorzy :
Nielsen, Helene MyrtueAff1, Aff2, Aff3
Andersen, Christen LykkegaardAff1, Aff4
Westman, Maj
Kristensen, Lasse Sommer
Asmar, Fazila
Kruse, Torben Arvid
Thomassen, Mads
Larsen, Thomas Stauffer
Skov, Vibe
Hansen, Lise Lotte
Bjerrum, Ole Weis
Hasselbalch, Hans Carl
Punj, Vasu
Grønbæk, KirstenAff1, Aff3
Pokaż więcej
Źródło :
Scientific Reports. 7(1)
Czasopismo naukowe
Tytuł :
Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response
Autorzy :
Knudsen, Trine Alma
Skov, Vibe
Werner, Lillian
Duke, William
Gibson, Christopher J.
Nag, Anwesha
Thorner, Aaron R.
Wollison, Bruce
Lund Hansen, Dennis
Larsen, Thomas Stauffer
Ellervik, Christina
El Fassi, Daniel
de Stricker, Karin
Ocias, Lukas Frans
Brabrand, Mette
Weiss Bjerrum, Ole
Overgaard, Ulrik Malthe
Frederiksen, Mikael
Kielsgaard Kristensen, Thomas
Kruse, Torben A
Thomassen, Mads
Mourits-Andersen, Torben
Severinsen, Marianne Tang
Jesper, Stentoft
Starklint, Jørn
Møller, Peter
Neuberg, Donna S.
Kjær, Lasse
Hasselbalch, Hans Carl
Coleman Lindsley, R
Mullally, Ann
Pokaż więcej
Źródło :
Knudsen, T A, Skov, V, Werner, L, Duke, W, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Lund Hansen, D, Larsen, T S, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Weiss Bjerrum, O, Overgaard, U M, Frederiksen, M, Kielsgaard Kristensen, T, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Jesper, S, Starklint, J, Møller, P, Neuberg, D S, Kjær, L, Hasselbalch, H C, Coleman Lindsley, R & Mullally, A 2019, ' Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response ', American Society of Hematology: 61st Annual Meeting (ASH), Orlando, United States, 07/12/2019 - 10/12/2019 .
Tytuł :
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Autorzy :
Sørensen, Anders Lindholm
Mikkelsen, Stine Ulrik
Knudsen, Trine Alma
Bjørn, Mads Emil
Andersen, Christen Lykkegaard
Bjerrum, Ole Weis
Brochmann, Nana
Patel, Dustin Andersen
Rahbek Gjerdrum, Lise Mette
El Fassi, Daniel
Kruse, Torben A.
Larsen, Thomas Stauffer
Mourits-Andersen, Hans Torben
Nielsen, Claus Henrik
Ellervik, Christina
Pallisgaard, Niels
Thomassen, Mads
Kjær, Lasse
Skov, Vibe
Hasselbalch, Hans Carl
Pokaż więcej
Źródło :
Haematologica: The Hematology Journal; Sep2020, Vol. 105 Issue 9, p2262-2272, 11p
Czasopismo naukowe
Tytuł :
IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA-2 OR HYDROXYUREA IN THE DALIAH TRIAL
Autorzy :
Andersen Patel, Dustin
Knudsen, Trine Alma
Lund Hansen, Dennis
Ocias, Lucas Frans
Weiss Bjerrum, Ole
Brabrand, Mette
Ellervik, Christina
el Fassi, Daniel
Frederiksen, Mikael
Kjær, Lasse
Kielsgaard Kristensen, Thomas
Kruse, Torben
Mourits-Andersen, Hans Torben
Møller, Peter
Overgaard, Ulrik Malthe
Severinsen, Marianne Tang
Skov, Vibe
Lindholm Sørensen, Anders
Jesper, Stentoft
Starklint, Jørn
de Stricker, Karin
Thomassen, Mads
Larsen, Thomas Stauffer
Hasselbalch, Hans Carl
Pokaż więcej
Źródło :
Andersen Patel, D, Knudsen, T A, Lund Hansen, D, Ocias, L F, Weiss Bjerrum, O, Brabrand, M, Ellervik, C, el Fassi, D, Frederiksen, M, Kjær, L, Kielsgaard Kristensen, T, Kruse, T, Mourits-Andersen, H T, Møller, P, Overgaard, U M, Severinsen, M T, Skov, V, Lindholm Sørensen, A, Jesper, S, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2019, ' IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA-2 OR HYDROXYUREA IN THE DALIAH TRIAL ', HemaSphere, vol. 2019, PB2210 .
Tytuł :
Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma
Autorzy :
Biccler, Jorne Lionel
Savage, Kerry J.
Brown, Peter de Nully
Jorgensen, Judit
Larsen, Thomas Stauffer
Poulsen, Christian Bjorn
Stoltenberg, Danny
Jakobsen, Lasse H.
Bogsted, Martin
Villa, Diego
El-Galaly, Tarec C.
Pokaż więcej
Źródło :
Biccler, J L, Savage, K J, Brown, P D N, Jorgensen, J, Larsen, T S, Poulsen, C B, Stoltenberg, D, Jakobsen, L H, Bogsted, M, Villa, D & El-Galaly, T C 2018, ' Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma ', Blood, vol. 132, no. Suppl. 1, pp. 1699 . https://doi.org/10.1182/blood-2018-99-114191
Tytuł :
Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial
Autorzy :
Knudsen, Trine Alma
Hansen, Dennis Lund
Ocias, Lukas Frans
Bjerrum, Ole Weis
Brabrand, Mette
El Fassi, Daniel
Frederiksen, Mikael
Kjaer, Lasse
Kristensen, Thomas Kielsgaard
Kruse, Torben A.
Mourits-Andersen, Torben
Moller, Peter
Overgaard, Ulrik Malthe
Severinsen, Marianne Tang
Skov, Vibe
Stentoft, Jesper
Starklint, Jorn
de Stricker, Karin
Thomassen, Mads
Larsen, Thomas Stauffer
Hasselbalch, Hans Carl
Pokaż więcej
Źródło :
Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjaer, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Moller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. 1 . https://doi.org/10.1182/blood-2018-99-111255
Tytuł :
Erratum to:Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations (Scientific Reports, (2017), 7, 1, (6774), 10.1038/s41598-017-07057-3)
Autorzy :
Hansen, Lise Lotte
Nielsen, Helene Myrtue
Andersen, Christen Lykkegaard
Westman, Maj
Kristensen, Lasse Sommer
Asmar, Fazila
Kruse, Torben Arvid
Thomassen, Mads
Larsen, Thomas Stauffer
Skov, Vibe
Bjerrum, Ole Weis
Hasselbalch, Hans Carl
Punj, Vasu
Grønbæk, Kirsten
Pokaż więcej
Temat :
Publisher Correction
Science
Medicine
Źródło :
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
Nielsen, H M, Andersen, C L, Westman, M, Kristensen, L S, Asmar, F, Kruse, T A, Thomassen, M, Larsen, T S, Skov, V, Hansen, L L, Bjerrum, O W, Hasselbalch, H C, Punj, V & Grønbæk, K 2018, ' Erratum to : Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations (Scientific Reports, (2017), 7, 1, (6774), 10.1038/s41598-017-07057-3) ', Scientific Reports, vol. 8, no. 1, 17311 . https://doi.org/10.1038/s41598-018-35596-w
Nielsen, H M, Andersen, C L, Westman, M, Kristensen, L S, Asmar, F, Kruse, T A, Thomassen, M, Larsen, T S, Skov, V, Hansen, L L, Bjerrum, O W, Hasselbalch, H C, Punj, V & Grønbæk, K 2018, ' Publisher Correction : Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations (Scientific Reports, (2017), 7, 1, (6774), 10.1038/s41598-017-07057-3) ', Scientific Reports, vol. 8, 17311 . https://doi.org/10.1038/s41598-018-35596-w
Opis pliku :
application/pdf

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies